Tag: COVID-19
-
Tracking the Evolution of COVID-19
Scientists have developed a machine-learning approach to track the evolution of the COVID-19 virus and potentially others, according to a study published in the Proceedings of the National Academy of Sciences.
-
Study Explores Characteristics Associated with Poor COVID-19 Antibody Response
U.S. adults with certain socio-demographic and clinical characteristics may have weaker antibody responses to COVID-19 vaccination, according to a recent study published in Nature Communications.
-
Study Examines Performance of Serial COVID Testing
Testing performance of rapid antigen tests for SARS-CoV-2 improved for both asymptomatic and symptomatic patients after testing multiple times in 48-hour intervals, according to findings published in the Annals of Internal Medicine.
-
Metformin May Prevent Long COVID, Trial Finds
Metformin, a drug commonly used to treat diabetes, may prevent the development of “long COVID,” according to a clinical trial published in The Lancet Infectious Diseases.
-
Bioengineered Protein May Prevent COVID Infections and Improve Survival
A novel protein developed by Northwestern Medicine investigators improved survival and prevented brain infection in mice infected with SARS-CoV-2 when administered intranasally, according to a recent study.
-
Secondary Bacterial Pneumonia Drove Many COVID-19 Deaths
Secondary bacterial pneumonia that did not resolve was a key driver of death in patients with COVID-19, according to a recent study in the Journal of Clinical Investigation.
-
First COVID-19 Vaccination Can ‘Hurt’ Subsequent Boosters
A new Northwestern Medicine study shows antibodies generated by prior vaccinations or infections can actually “hurt” subsequent COVID-19 booster shots.
-
Northwestern Investigates COVID-19: Maternal Vaccinations, Burnout and Therapeutic Targets
Northwestern Medicine investigators continue to study the impact of the COVID-19 pandemic on health outcomes and society, from maternal vaccinations and antibody response to reducing burnout amongst healthcare workers and identifying novel therapeutic targets.
-
Novel Monoclonal Antibody Therapy for SARS-CoV-2
Targeting internal proteins instead of spike proteins may be a promising strategy for monoclonal antibody therapy to combat SARS-CoV-2, the virus that causes COVID-19.
-
Northwestern Investigates COVID-19: Sentinel Surveillance, ‘Long COVID’ in Children
Northwestern Medicine investigators continue to investigate the impact of the COVID-19 pandemic, from evaluating repurposed drugs in preventing severe disease to using sentinel surveillance to monitor SARS-CoV-2 transmission rates and studying the prevalence of “long COVID” in pediatric patients.
